Overview

The Effects of Different Loading Doses of Dexmedetomidine on The Bispectral Index-Guided Propofol Sedation in Patients Undergoing Advanced Upper Gastrointestinal Endoscopic Procedures: A Randomized Control Study

Status:
RECRUITING

Trial end date:
2024-10-01

Target enrollment:

Participant gender:

Summary

Propofol is currently the most common drug used but has drawbacks like narrow therapeutic window and potential complications. Dexmedetomidine is an attractive alternative due to its unique properties like minimal respiratory depression. Studies are ongoing to find the optimal use of dexmedetomidine for these procedures. A combination of propofol and dexmedetomidine might be ideal, but the best balance between the two drugs needs further investigation.

Phase:

PHASE4

Details

Lead Sponsor:

Theodor Bilharz Research Institute

Treatments:

Dexmedetomidine
Injections